Crit Care Med:心脏手术后心输出量的心率修正!

2017-04-25 xing.T MedSci原创

超声心动图引导的心率优化可以显著增加心脏输出,相比于术后的临床衍生的起搏设置。最佳心率应根据每个病人实现个体化,总的等容时间是灵敏度最高的超声心动图指标来确定最佳的血流动力学。

心输出量不足与心脏手术后的预后较差有关,通常通过使用正性肌力药、容积复苏和起搏来进行调整。超声指导下的起博优化主要用于门诊患者,通过使用不同的变量,包括总的等容时间和Tei指数。近日,危重病医学领域权威杂志Critical Care Medicine上发表了一篇研究文章,研究人员旨在明确心率对围手术期心脏电机械学、心输出量、每搏量的影响。

该研究为观察性研究,是心胸外科成人重症监护室完成。以24个连续就诊的心脏手术后患者为研究对象。患者起搏器的设置是由治疗麻醉师根据血流动力学参数完成的,回到重症监护4小时内,他们重新使用经胸超声心动图进行评估。研究人员进行了一个全面的基线超声心动图研究,通过临床医生设置RR间隔和心率从70到110次/分,增量为10次/分。皮尔森相关系数被用来评估测量指标之间的相关性。

79%使用超声心动图引导起搏器优化的患者心脏输出量和心脏指数显着增加(分别为2.21L/min±0.97和1.2L/min/m2±0.52)。超声心动图驱动的心脏输出优化方案导致在整体人群中总的等容时间减少,同时心输出量和心脏指数增加(P<0.001)。整体人群中RR间期和心搏量、心输出量或心脏指数之间没有一致的相关性。在所有组中左心室总的等容时间、每搏量、心输出量和心脏指数之间被发现具有强烈的负相关关系。

超声心动图引导的心率优化可以显著增加心脏输出,相比于术后的临床衍生的起搏设置。最佳心率应根据每个病人实现个体化,总的等容时间是灵敏度最高的超声心动图指标来确定最佳的血流动力学。

原始出处:

Tavazzi, Guido, et al. Heart Rate Modification of Cardiac Output Following Cardiac Surgery: The Importance of Cardiac Time Intervals.Critical Care Medicine.2017. http://journals.lww.com/ccmjournal/Abstract/publishahead/Heart_Rate_Modification_of_Cardiac_Output.96624.aspx

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=194508, encodeId=fb54194508d4, content=文章不错,值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat May 06 10:01:09 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194147, encodeId=534919414e6c, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Fri May 05 12:41:30 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370509, encodeId=7e9e13e0509a1, content=<a href='/topic/show?id=fb68519e80e' target=_blank style='color:#2F92EE;'>#心输出量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51978, encryptionId=fb68519e80e, topicName=心输出量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607431, encodeId=4333160e431bc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190947, encodeId=cf6219094e35, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Thu Apr 27 06:12:25 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190669, encodeId=534019066939, content=文章很好,拜读了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Apr 26 08:06:28 CST 2017, time=2017-04-26, status=1, ipAttribution=)]
    2017-05-06 1e10c84am36(暂无匿称)

    文章不错,值得拜读

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=194508, encodeId=fb54194508d4, content=文章不错,值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat May 06 10:01:09 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194147, encodeId=534919414e6c, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Fri May 05 12:41:30 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370509, encodeId=7e9e13e0509a1, content=<a href='/topic/show?id=fb68519e80e' target=_blank style='color:#2F92EE;'>#心输出量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51978, encryptionId=fb68519e80e, topicName=心输出量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607431, encodeId=4333160e431bc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190947, encodeId=cf6219094e35, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Thu Apr 27 06:12:25 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190669, encodeId=534019066939, content=文章很好,拜读了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Apr 26 08:06:28 CST 2017, time=2017-04-26, status=1, ipAttribution=)]
    2017-05-05 cuiyejia

    学习了,谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=194508, encodeId=fb54194508d4, content=文章不错,值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat May 06 10:01:09 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194147, encodeId=534919414e6c, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Fri May 05 12:41:30 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370509, encodeId=7e9e13e0509a1, content=<a href='/topic/show?id=fb68519e80e' target=_blank style='color:#2F92EE;'>#心输出量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51978, encryptionId=fb68519e80e, topicName=心输出量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607431, encodeId=4333160e431bc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190947, encodeId=cf6219094e35, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Thu Apr 27 06:12:25 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190669, encodeId=534019066939, content=文章很好,拜读了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Apr 26 08:06:28 CST 2017, time=2017-04-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=194508, encodeId=fb54194508d4, content=文章不错,值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat May 06 10:01:09 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194147, encodeId=534919414e6c, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Fri May 05 12:41:30 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370509, encodeId=7e9e13e0509a1, content=<a href='/topic/show?id=fb68519e80e' target=_blank style='color:#2F92EE;'>#心输出量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51978, encryptionId=fb68519e80e, topicName=心输出量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607431, encodeId=4333160e431bc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190947, encodeId=cf6219094e35, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Thu Apr 27 06:12:25 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190669, encodeId=534019066939, content=文章很好,拜读了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Apr 26 08:06:28 CST 2017, time=2017-04-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=194508, encodeId=fb54194508d4, content=文章不错,值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat May 06 10:01:09 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194147, encodeId=534919414e6c, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Fri May 05 12:41:30 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370509, encodeId=7e9e13e0509a1, content=<a href='/topic/show?id=fb68519e80e' target=_blank style='color:#2F92EE;'>#心输出量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51978, encryptionId=fb68519e80e, topicName=心输出量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607431, encodeId=4333160e431bc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190947, encodeId=cf6219094e35, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Thu Apr 27 06:12:25 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190669, encodeId=534019066939, content=文章很好,拜读了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Apr 26 08:06:28 CST 2017, time=2017-04-26, status=1, ipAttribution=)]
    2017-04-27 ylzr123

    认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦……

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=194508, encodeId=fb54194508d4, content=文章不错,值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sat May 06 10:01:09 CST 2017, time=2017-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194147, encodeId=534919414e6c, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28761705280, createdName=cuiyejia, createdTime=Fri May 05 12:41:30 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370509, encodeId=7e9e13e0509a1, content=<a href='/topic/show?id=fb68519e80e' target=_blank style='color:#2F92EE;'>#心输出量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51978, encryptionId=fb68519e80e, topicName=心输出量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68f2317, createdName=天堂的云, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607431, encodeId=4333160e431bc, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Apr 27 10:49:00 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190947, encodeId=cf6219094e35, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦……, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Thu Apr 27 06:12:25 CST 2017, time=2017-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=190669, encodeId=534019066939, content=文章很好,拜读了, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Apr 26 08:06:28 CST 2017, time=2017-04-26, status=1, ipAttribution=)]
    2017-04-26 1e10c84am36(暂无匿称)

    文章很好,拜读了

    0

相关资讯

Anesthesiology:Presepsin(sCD14-ST)----心脏手术患者风险分级的新标志

麻醉疼痛科: Presepsin(sCD14-ST):心脏手术患者风险分级的新标志Presepsin(可溶性 CD14 亚型,sCD14-ST)是全身炎症反应综合征和败血症的风险分级的体液标记物。 为了研究presepsin能否作为选择性心脏手术患者风险分级的新标记物,作者以八百五十六名心脏手术患者为研究对象,将其术前血浆中这些标记物(preepsin,降钙素原,N-末端促尿钠肽,半胱氨酸蛋白酶抑

[ACC2017]LEVO-CTS:左西孟旦在心脏手术中的作用

华盛顿时间3月19日早8点,来自第66届ACC年会上发布的一项最新临床研究——LEVO-CTS表明,心脏手术时,心衰治疗药物左西孟旦作为一种预防措施,不显著降低死亡率、心脏病发作率、肾透析率以及低心输出量综合征高危患者的机械辅助装置使用率。该研究同期发表于《新英格兰医学杂志》。

NEJM:心脏手术后左西孟旦血流动力学支持疗效如何?

心脏手术后需要围手术期血流动力学支持的患者,低剂量的左西孟旦加上标准的治疗相比于安慰剂治疗并没有降低30天死亡率。

NEJM:氨甲环酸治疗接受心脏手术患者,益处和风险并存

氨甲环酸降低了接受心脏手术患者的出血风险,但目前尚不清楚这是否会改善患者的预后。此外,人们还担忧氨甲环酸可能会有促血栓形成和致痫作用。在该项2×2析因设计的试验中,研究人员随机分配预计接受冠状动脉手术并且有围手术期并发症风险的患者接受阿司匹林或安慰剂,氨甲环酸或安慰剂。研究人员还报告了氨甲环酸比较的结果。主要结果是手术后30天内的死亡和血栓性并发症(非致死性心肌梗死,卒中,肺栓塞,肾衰竭或肠梗塞)

NEJM:左心室功能不全的接受心脏手术的患者接受左西孟旦治疗疗效如何?

在左室射血分数降低并接受体外循环心脏手术的患者中,预防性左西孟旦并未导致包含死亡、脏替代治疗、围手术期心肌梗死或使用机械心脏辅助装置的短期复合终点较安慰剂组要低。

JAHA:肥胖会增加心脏手术后风险调整的发病率、死亡率和医疗成本!

较高的BMI与死亡率、重大疾病和医院医疗成本增加有关。因此,在风险评估和资源分配中,BMI应重点考虑。